From Dipyrrolonaphthyridinediones to Quinazolinoindolizinoindolizinoquinazolines

Dipyrrolonaphthyridinedione - (still) a mysterious cross-conjugated chromophore

Dipyrrolonaphthyridinediones (DPNDs) entered the chemical world in 2016. This cross-conjugated donor-acceptor skeleton can be prepared in two steps from commercially available reagents in overall yield ≈15-20% (5 mmol scale). DPNDs can be easily and regioselectively halogenated which opens an avenue to numerous derivatives as well as to π-expansion. Although certain synthetic limitations exist, the current derivatization possibilities provided impetus for numerous explorations that use DPNDs. Structural modifications enable bathochromic shift of the emission to deep-red region and reaching the optical brightness 30 000 M-1 cm-1. Intense absorption and strong emission of greenish-yellow light attracted the interest which eventually led to the discovery of their strong two-photon absorption, singlet fission in the crystalline phase and triplet sensitization. Dipyrrolonaphthyridinedione-based twistacenes broadened our knowledge on the influence of twisting angle on the fate of the molecule in the excited state. Collectively, these findings highlight the compatibility of DPNDs with various applications within organic optoelectronics.

Photophysical Insights of Halogenated Dipyrrolonaphthyridine-Diones as Potential Photodynamic Therapy Agents†

We report the synthesis and photophysical characterization of novel halogenated dipyrrolonaphthyridine-diones (X2 -DPNDs, X = Cl, Br, and I), as candidates for photodynamic therapy (PDT) application. Apart from the heavy atom-induced spin-orbit coupling (SOC) dynamics in the investigated X2 -DPNDs, it was found that the position of the halogen atom (relative to the nitrogen of the pyrrole ring) also influenced the triplet excited state behavior. Interestingly, the faster/efficiency sensitization of 3 O2 to 1 O2 using X2 -DPND correlates with the rate of triplet population, kISC  >1.6 × 108 s-1 for I2 -DPND vs kISC  >2.9 × 109 s-1 for Cl2 -DPND and Br2 -DPND (where τISC  = 343 ± 3 ps for I2 -DPND and τISC  = 5-6 ns for Cl2 -DPND and Br2 -DPND are the lowest time constants/values for ISC). Furthermore, the heavy atom-induced SOC in Cl2 -DPND and Br2 -DPND did not lead to a reduction of the corresponding fluorescence (ca 75% vs 67% for the parent DPND). The attractive photophysical characteristics of Cl2 /Br2 -DPND put them on the landscape as not only promising PDT agents but also as fluorescence probes. The present study is a stepping stone in the development of novel organic photosystems for synergistic photomedicinal applications.